All Categories

Long-term outcomes of total correction for isolated total anomalous pulmonary venous connection: lessons from 50-years’ experience

Takahiko Sakamoto, Mitsugi Nagashima, Kentarou Umezu, Ryogo Houki, Jin Ikarashi, Junko Katagiri, Kenji YamazakiThe Heart Institute of Japan and Tokyo Women’s Medical University.Japan Interactive Cardiovascular and Thoracic SurgeryInteract Cardiovasc Thorac Surg 2018; 27: 20-26DOI: 10.1093/icvts/ivy034 AbstractObjectives: Isolated total anomalous pulmonary venous connection (TAPVC) is a relatively rare congenital cardiac defect, while pulmonary venous obstruction (PVO) is associated […]

Long-term outcomes of total correction for isolated total anomalous pulmonary venous connection: lessons from 50-years’ experience Read More »

Surgical management of total anomalous pulmonary venous connection. Thirty-year trends

Ko Bando, Mark W. Turrentine, Gregory J. Ensing, K. Sun, Thomas G. Sharp Y. Sekine, Donald A. Girod, John W. BrownJames W. Riley Hospital for Children.United States CirculationCirculation 1996; 94(9 Suppl): II12-II16DOI: Not Available AbstractBackground: Reports of surgical correction of total anomalous pulmonary venous connection (TAPVC) over the past 30 years indicate a general improvement in

Surgical management of total anomalous pulmonary venous connection. Thirty-year trends Read More »

Congenital pulmonary lymphangiectasis associated with a blind common pulmonary vein

Arkadi M. Rywlin, Rita M. FojacoUniversity of Miami.United States Pediatrics Pediatrics 1968; 41: 931–934https://doi.org/10.1542/peds.41.5.931 AbstractThree main theories have to be considered in the pathogenesis of congenital pulmonary lymphangectasis: obstruction of major pulmonary lymphatics, obstruction to pulmonary venous flow, and anomalous pulmonary development. The authors report an infant with congenital pulmonary lymphangiectasis associated with a blind common

Congenital pulmonary lymphangiectasis associated with a blind common pulmonary vein Read More »

Total anomalous pulmonary venous connection: clinical and physiologic observations of 75 pediatric patients

Gary E. Gathman, Alexander S. NadasBoston Children’s Hospital and Harvard Medical SchoolUnited States CirculationCirculation 1970; 42: 143-154DOI: 10.1161/01.cir.42.1.143 SummaryExperience with 75 cases of proven total anomalous pulmonary venous connection without other significant cardiac malformations treated at the Children’s Hospital Medical Center in Boston from January 1950 to June 1968 forms the basis of this report. Clinical

Total anomalous pulmonary venous connection: clinical and physiologic observations of 75 pediatric patients Read More »

Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm

Lindsey Beer, Brian K. Rivera, Waceys Jama, Jonathan L. Slaughter, Carl H. Backes, Sara Conroy, Matthew J. KieltNationwide Children’s Hospital, Abigail Wexner Research Institute at Nationwide Children’s Hospital and Ohio State University College of Medicine.United States Journal of PerinatologyJ Perinatol 2023; DOI: 10.1038/s41372-023-01798-y AbstractObjective: To test the hypothesis that elevations in the respiratory severity score (RSS) are

Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm Read More »

Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study

Eliana Rosenzweig, Gerson Antonio Valencia Villeda, Sarah Crook, Fatima Koli, Erika B. Rosenzweig, Usha S. KrishnanColumbia University Irving Medical Center and New York Presbyterian Hospital. Orlando Health Arnold Palmer Hospital for Children.United States Texas Heart Institue JournalTex Heart Inst J 2023; 50DOI: 10.14503/THIJ-22-7866 AbstractBackground: Patients with pulmonary arterial hypertension have quality-of-life limitations, decreased exercise capacity, and poor

Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study Read More »

Atresia of the common pulmonary vein: report of one case

Gita T. Mody, Gordan M. Folger, Jr.Henry Ford HospitalUnited States PediatricsPediatrics 1974; 54: 62-66DOI.org/10.1542/peds.54.1.62 AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary Hypertension Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article Access Free PDF File or Full Text Article Available

Atresia of the common pulmonary vein: report of one case Read More »

Modified superior approach for repair of supracardiac and mixed total anomalous pulmonary venous drainage

Alain Serraf, Emré Belli, Danie lRoux, Miguel Sousa-Uva, Francois Lacour-Gayet, Claude PlanchéMarie-Lannelongue Hospital.France Annals of Thoracic SurgeryAnn Thorac Surg 1998; 65: 1391-1393DOI: 10.1016/s0003-4975(98)00141-6 AbstractBackground: The main goal in the surgical repair of total anomalous pulmonary venous drainage is to reestablish a wide patent connection between the common pulmonary vein and the left atrium. Several techniques have been

Modified superior approach for repair of supracardiac and mixed total anomalous pulmonary venous drainage Read More »

Failure of Pulmonary Venous Atrioplasy to Relieve Pulmonary Venous Obstruction Following Mustard’s Operation

David J. Driscoll, Michael R. Nihill, Denton A. CooleyBaylor College of Medicine and the Texas Heart Institute.United States Cardiovascular DiseasesCardiovasc Dis 1976; 3: 430-437DOI: Not Available AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary Hypertension Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years

Failure of Pulmonary Venous Atrioplasy to Relieve Pulmonary Venous Obstruction Following Mustard’s Operation Read More »

Loss of Prolyl Hydroxylase 1 and 2 in SM22α-Expressing Cells Prevents Hypoxia-Induced Pulmonary Hypertension

Elizabeth A. Barnes, Reiji Ito, Xibing Che, Cristina M. Alvira, David N. CornfieldStanford University.United States and Japan American Journal of Physiology Lung Cellular and Molecular PhysiologyAm J Physiol Lung Cell Mol Physiol 2023; DOI: 10.1152/ajplung.00428.2022 AbstractPulmonary arterial hypertension (PAH) is a disease characterized by increased vasoconstriction and vascular remodeling. Pulmonary artery smooth muscle cells (PASMC) highly

Loss of Prolyl Hydroxylase 1 and 2 in SM22α-Expressing Cells Prevents Hypoxia-Induced Pulmonary Hypertension Read More »

Scroll to Top